GGI
RVPH

Godsey & Gibb Inc’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Godsey & Gibb Inc’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-55
Closed -$1.99K – 399
2024
Q4 		$1.99K Sell
55
-25
-31% -$696 ﹤0.01% 340
2024
Q3 		$2.3K Buy
+80
New +$1.78K ﹤0.01% 400

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Godsey & Gibb Inc's RVPH Position: Q1 2025 in Review

Godsey & Gibb Inc sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2025, closing a stake of 55 shares — an estimated $1.99K sold.

Godsey & Gibb Inc first reported a position in RVPH in Q3 2024 and held it in 2 quarters. The position peaked at $2.3K in Q3 2024. 48 funds tracked by Wall St. Rank hold RVPH as of Q1 2025.

  • Godsey & Gibb Inc reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2025 after selling out during the quarter.
  • Godsey & Gibb Inc sold 55 REVIVA PHARMA HLDGS INC shares in Q1 2025, an estimated $1.99K.
  • Godsey & Gibb Inc first reported a position in REVIVA PHARMA HLDGS INC in Q3 2024 and held it in 2 quarters.
  • Godsey & Gibb Inc's REVIVA PHARMA HLDGS INC position peaked at $2.3K in Q3 2024.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2025.

Based on Godsey & Gibb Inc's 13F filing for Q1 2025, filed 11 Apr 2025.